Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...

Eli Lilly, the maker of blockbuster weight ... shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals. Three of the sites will make active ...

Eli Lilly (LLY) stock in focus as company boosts U.S. medicine production investment to $50B, creating 3,000 skilled jobs & 10,000 construction roles. Read more here.

Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs.

Feb 26 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to ... The announcement comes less than a week after U.S. President Donald Trump met with chief executives from major drugmakers ...